USAA
ARRY

United Services Automobile Association’s Array Biopharma Inc ARRY Stock Holding History

United Services Automobile Association’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-33,612
Closed -$1.56M – 2165
2019
Q2 		$1.56M Hold
33,612
– – ﹤0.01% 1171
2019
Q1 		$819K Buy
33,612
+1,662
+5% +$34.6K ﹤0.01% 1406
2018
Q4 		$455K Hold
31,950
– – ﹤0.01% 1602
2018
Q3 		$486K Hold
31,950
– – ﹤0.01% 1696
2018
Q2 		$536K Sell
31,950
-283,850
-90% -$4.52M ﹤0.01% 1655
2018
Q1 		$5.15M Sell
315,800
-57,200
-15% -$916K 0.01% 812
2017
Q4 		$4.77M Sell
373,000
-28,000
-7% -$318K 0.01% 819
2017
Q3 		$4.93M Sell
401,000
-168,000
-30% -$1.56M 0.01% 768
2017
Q2 		$4.76M Sell
569,000
-521,000
-48% -$4.26M 0.01% 759
2017
Q1 		$9.74M Buy
1,090,000
+536,110
+97% +$5.7M 0.03% 538
2016
Q4 		$4.87M Buy
+553,890
New +$4.08M 0.02% 738

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

United Services Automobile Association's ARRY Position: Q3 2019 in Review

United Services Automobile Association sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 33,612 shares — an estimated $1.56M sold.

United Services Automobile Association first reported a position in ARRY in Q4 2016 and held it in 11 quarters. The position peaked at $9.74M in Q1 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • United Services Automobile Association reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 33,612 Array Biopharma Inc shares in Q3 2019, an estimated $1.56M.
  • United Services Automobile Association first reported a position in Array Biopharma Inc in Q4 2016 and held it in 11 quarters.
  • United Services Automobile Association's Array Biopharma Inc position peaked at $9.74M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.